✦ LIBER ✦

Psychosocial Treatments for Major Depression and Dysthymia in Older Adults: A Review of the Research Literature

✍ Scribed by Carlos P. Zalaquett; Andrea N. Stens

Publisher: American Counseling Association
Year: 2006
Tongue: English
Weight: 112 KB
Volume: 84
Category: Article
ISSN: 1556-6678
DOI: 10.1002/j.1556-6678.2006.tb00395.x

No coin nor oath required. For personal study only.

✦ Synopsis

Older adults represent a growing segment of the population with the highest suicide rate and an increasing need of counseling services for major depression and dysthymia. The present study examined the literature with the purpose of identifying research addressing psychosocial treatments of depression in later life. A summary of treatments currently supported by research as being efficacious when treating older individuals experiencing depression or dysthymia is presented. Limitations of the findings are discussed.

📜 SIMILAR VOLUMES

Predicting the onset of major depressive

Predicting the onset of major depressive disorder and dysthymia in older adults with subthreshold depression: a community based study

✍ Pim Cuijpers; Aartjan Beekman; Filip Smit; Dorly Deeg 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 87 KB 👁 2 views

## Abstract ## Background It is well‐established that the incidence of major depressive disorder is increased in subjects with subthreshold depression. A new research area focuses on the possibilities of preventing the onset of major depressive disorders in subjects with subthreshold depression. A

The efficacy and safety of ECT in depres

The efficacy and safety of ECT in depressed older adults: a literature review

✍ F. B. van der Wurff; M. L. Stek; W. J. G. Hoogendijk; A. T. F. Beekman 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 101 KB 👁 1 views

## Abstract ## Background Although little doubt exists among practising clinicians in old age psychiatry about the efficacy and safety of ECT in depression, opinions about acceptability differ widely. The objectives of this review were to determine the efficacy and safety of ECT based on both rand

Deliberate self-harm in older adults: a

Deliberate self-harm in older adults: a review of the literature from 1995 to 2004

✍ Jenifer Chan; Brian Draper; Sube Banerjee 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 146 KB 👁 1 views

## Abstract ## Background The prevention of suicide is a national and international policy priority. Old age is an important predictor of completed suicide. Suicide rates in old age differ markedly from country to country but there is a general trend towards increasing rates with increasing age. I

Supporting dyslexic adults—a need for cl

Supporting dyslexic adults—a need for clarity (and more research): a critical review of the rice report ‘Developmental dyslexia in adults: a research review’

✍ Linda S. Siegel; Ian S. Smythe 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 83 KB 👁 1 views

Evidence based teaching methods are desirable not only for economic efficiency but also important for ensuring the learner is engaged in meaningful activity. Therefore, a review of the research that could inform both teaching practice and future research is to be welcomed. However, the NRDC review '

Adipokines and the risk of fracture in o

Adipokines and the risk of fracture in older adults

✍ Kamil E Barbour; Joseph M Zmuda; Robert Boudreau; Elsa S Strotmeyer; Mara J Horw 📂 Article 📅 2011 🏛 American Society for Bone and Mineral Research 🌐 English ⚖ 111 KB 👁 1 views

## Abstract Adiponectin and leptin are adipokines that influence bone metabolism in vitro and in animal models. However, less is known about the longitudinal association of leptin and adiponectin with fracture. We tested the hypothesis that low leptin and high adiponectin levels are each individual

Use of paroxetine for the treatment of d

Use of paroxetine for the treatment of depression and anxiety disorders in the elderly: a review

✍ Michel Bourin 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 67 KB 👁 1 views

## Abstract Paroxetine is a potent selective serotonin reuptake inhibitor (SSRI) with indications for the treatment of depression, obsessive– compulsive disorder, panic disorder and social phobia. It is also used in the treatment of generalized anxiety disorder, post‐traumatic stress disorder, prem